Novel autoantibodies in autoimmune hepatitis: from diagnostic challenges to molecular and spatial pathology

Read full text Summarise with VIRAT
Authors: Kazumichi Abe, Jun Wada, Manabu Hayashi, Tatsuro Sugaya, Naoto Abe, Masashi Fujita, Hiromasa Ohira
Cited by: 0
References: 21

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Autoimmune hepatitis (AIH) lacks a single disease-specific diagnostic test, particularly in acute-onset or seronegative cases with normal IgG levels. Recent progress in high-throughput autoantibody profiling has enabled systematic and unbiased identification of novel autoantibodies, offering new insights into disease diagnosis and underlying pathogenic mechanisms. This review summarizes emerging autoantibodies in AIH, primarily focusing on antibodies identified through proteome-wide approaches. We highlight anti-docking protein 2 (DOK2) antibodies, identified using a human protein microarray and validated by ELISA, immunohistochemistry, and imaging mass cytometry. These antibodies exhibit high diagnostic performance, including in patients with IgG-normal and ANA-negative AIH, and are correlated with disease activity. Spatial analyses revealed that DOK2 was expressed predominantly in hepatic macrophages and subsets of T cells, providing mechanistic insight into immune regulation in AIH. These findings illustrate how integrative serological and molecular morphology approaches can refine AIH diagnosis and deepen the understanding of disease pathogenesis.

Fields of Study & Subjects

Liver Diseases and Immunity IgG4-Related and Inflammatory Diseases Drug-Induced Hepatotoxicity and Protection

Publication details

Journal / source
Medical Molecular Morphology
Volume
59
Issue
2
Pages
85–92
Publication date
26 March 2026
Language
EN